Trial Profile
MK0476 Phase III Long-term Study -Perennial Allergic Rhinitis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Perennial allergic rhinitis
- Focus Adverse reactions
- Sponsors Organon
- 14 Mar 2013 Actual end date changed from Aug 2005 to Feb 2005 as reported by ClinicalTrials.gov.
- 25 Oct 2008 New trial record.